Yokoyama, S., Perera, P., Terawaki, S., Watanabe, N., Kaminuma, O., Waldmann, T. A., . . . Perera, L. P. (2015). Janus Kinase Inhibitor Tofacitinib Shows Potent Efficacy in a Mouse Model of Autoimmune Lymphoproliferative Syndrome (ALPS). J Clin Immunol.
Chicago-tyylinen lähdeviittausYokoyama, Seiji, Pin-Yu Perera, Seigo Terawaki, Nobumasa Watanabe, Osamu Kaminuma, Thomas A. Waldmann, Takachika Hiroi, ja Liyanage P. Perera. "Janus Kinase Inhibitor Tofacitinib Shows Potent Efficacy in a Mouse Model of Autoimmune Lymphoproliferative Syndrome (ALPS)." J Clin Immunol 2015.
MLA-viiteYokoyama, Seiji, et al. "Janus Kinase Inhibitor Tofacitinib Shows Potent Efficacy in a Mouse Model of Autoimmune Lymphoproliferative Syndrome (ALPS)." J Clin Immunol 2015.